[1]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2019/14352,2019,A1Locationinpatent:Paragraph001270;001271
[2]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2020/146682,2020,A1Locationinpatent:Paragraph00570
1227499-98-0
1227515-52-7
1256807-03-0
80194-69-0
859538-41-3
1803834-87-8
89570-83-2 | (3-Trifluoromethylpyrid-2-yl)hydrazine | AA003XUS | MFCD01320804
89782-62-7 | N-(5-Amino-1,3,4-thiadiazol-2-yl)benzenesulfonamide | AA003ZU1 | MFCD11858099
892502-09-9 | 3-(1H-PYRAZOL-1-YLMETHYL)ANILINE | AA0041SE | MFCD03422525
887352-89-8 | N-BENZYL-7,8-DIMETHOXY-2,3,4,5-TETRAHYDRO-2-BENZAZEPINE-3-ONE | AA00444X | MFCD07367691
88982-82-5 | 4-Bromo-1,3-thiazole-2-carboxylic acid | AA0045HB | MFCD09701413
883526-76-9 | 1,5-Dimethyl-1h-indole-2-carbaldehyde | AA0046RG | MFCD06800611
885268-42-8 | tert-Butyl 2,7-diazaspiro[4.5]decane-2-carboxylate | AA0047YE | MFCD08234437
886374-01-2 | 5-Chloro-3-fluoro-2-methoxypyridine | AA0048ZT | MFCD07375056
88277-83-2 | 1,4-Dioxan-2-ylmethanamine | AA004A5M | MFCD01994527
88271-13-0 | Butanoic acid, 2-hydroxy-, ethyl ester, (2S)- | AA004BH7 | MFCD22418998